Extension Study for Patients Entered Into Study Infacort 003
NCT02733367
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Adrenal Insufficiency
Interventions
DRUG:
Infacort®
Sponsor
Neurocrine UK Limited